Cargando…

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy

BACKGROUND: MicroRNAs (miRNAs) are important regulators of cellular function and have been associated with both aging and cancer, but the impact of chemotherapy on age-related miRNAs has barely been studied. Our aim was to examine whether chemotherapy accelerates the aging process in elderly breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalmasso, Bruna, Hatse, Sigrid, Brouwers, Barbara, Laenen, Annouschka, Berben, Lieze, Kenis, Cindy, Smeets, Ann, Neven, Patrick, Schöffski, Patrick, Wildiers, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196565/ https://www.ncbi.nlm.nih.gov/pubmed/30348127 http://dx.doi.org/10.1186/s12885-018-4920-6

Ejemplares similares

Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status
por: Hatse, Sigrid, et al.
Publicado: (2014)

Biological ageing and frailty markers in breast cancer patients
por: Brouwers, Barbara, et al.
Publicado: (2015)

Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
por: Berben, Lieze, et al.
Publicado: (2020)

Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study
por: Wu, Qi, et al.
Publicado: (2022)

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
por: Brouwers, Barbara, et al.
Publicado: (2016)

Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy
por: Hatse, Sigrid, et al.
Publicado: (2022)

Blood Immunosenescence Signatures Reflecting Age, Frailty and Tumor Immune Infiltrate in Patients with Early Luminal Breast Cancer
por: Berben, Lieze, et al.
Publicado: (2021)

Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty
por: Bailur, Jithendra Kini, et al.
Publicado: (2017)

Cancer and Aging: Two Tightly Interconnected Biological Processes
por: Berben, Lieze, et al.
Publicado: (2021)

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Vos, Hanne, et al.
Publicado: (2021)

Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer
por: Lambrechts, Yentl, et al.
Publicado: (2023)

The footprint of the ageing stroma in older patients with breast cancer
por: Brouwers, Barbara, et al.
Publicado: (2017)

Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors
por: Lambrechts, Yentl, et al.
Publicado: (2023)

Is the sentinel lymph node biopsy more sensitive for the identification of positive lymph nodes in breast cancer than the axillary lymph node dissection?
por: Smeets, Ann, et al.
Publicado: (2013)

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors
por: Pfeil, Alena M, et al.
Publicado: (2014)

Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer
por: Smeets, Ann, et al.
Publicado: (2013)

Correlation of TROP-2 expression with clinical–pathological characteristics and outcome in triple-negative breast cancer
por: Izci, Hava, et al.
Publicado: (2022)

The impact of body mass index on age at breast cancer diagnosis and breast cancer phenotype
por: Brouckaert, Olivier, et al.
Publicado: (2015)

Oncological safety of autologous breast reconstruction after mastectomy for invasive breast cancer
por: Geers, Joachim, et al.
Publicado: (2018)

Validation of a prognostic scoring system for postmastectomy locoregional recurrence in breast cancer()
por: Van der Vorst, Aline, et al.
Publicado: (2022)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
por: De Cock, L., et al.
Publicado: (2021)

Retrospective Cohort Study of Practical Applications of Paramagnetic Seed Localisation in Breast Carcinoma and Other Malignancies
por: Clement, Céline, et al.
Publicado: (2022)

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
por: Van Nieuwenhuysen, Els, et al.
Publicado: (2019)

MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets
por: Verbiest, Annelies, et al.
Publicado: (2020)

A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial
por: Van der Gucht, Katleen, et al.
Publicado: (2020)

Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer
por: Dalmasso, Bruna, et al.
Publicado: (2023)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma
por: Kinget, Lisa, et al.
Publicado: (2021)

Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
por: Schroyen, Gwen, et al.
Publicado: (2021)

Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?
por: Van Baelen, Karen, et al.
Publicado: (2023)

Matrix Metalloproteinase Expression Patterns in Luminal A Type Breast Carcinomas
por: Decock, J., et al.
Publicado: (2007)

Molecular Comparison of Imatinib-Naïve and Resistant Gastrointestinal Stromal Tumors: Differentially Expressed microRNAs and mRNAs
por: Amirnasr, Azadeh, et al.
Publicado: (2019)

Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198
por: Schroyen, Gwen, et al.
Publicado: (2023)

Proteolytic Processing of ErbB4 in Breast Cancer
por: Hollmén, Maija, et al.
Publicado: (2012)

Role of microRNAs in Venous Thromboembolism
por: Morelli, Vânia M., et al.
Publicado: (2020)

Patient Selection in Human Papillomavirus Related Oropharyngeal Cancer: The Added Value of Prognostic Models in the New TNM 8th Edition Era
por: Deschuymer, Sarah, et al.
Publicado: (2018)

The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer
por: Nevens, Daan, et al.
Publicado: (2017)

Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer
por: Bollen, Heleen, et al.
Publicado: (2021)

Microbiota Modulate Host Gene Expression via MicroRNAs
por: Dalmasso, Guillaume, et al.
Publicado: (2011)

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
por: Lambertini, Matteo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t1s20hv7n5sacc54hhk2pig127